Table of Content

1 INTRODUCTION 24
1.1 STUDY OBJECTIVES 24
1.2 MARKET DEFINITION 24
1.2.1 INCLUSIONS & EXCLUSIONS 25
1.2.2 MARKET SEGMENTATION 26
1.2.3 YEARS CONSIDERED 27
1.2.4 CURRENCY CONSIDERED 27
1.3 LIMITATIONS 28
1.4 STAKEHOLDERS 28
1.5 SUMMARY OF CHANGES 28
2 RESEARCH METHODOLOGY 30
2.1 RESEARCH DATA 30
2.1.1 SECONDARY DATA 30
2.1.1.1 Key data from secondary sources 31
2.1.2 PRIMARY DATA 32
2.1.2.1 Key data from primary sources 33
2.1.2.2 Key industry insights 34
2.2 MARKET SIZE ESTIMATION 36
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 42
2.4 MARKET SHARE ANALYSIS 43
2.5 METHODOLOGY-RELATED LIMITATIONS 43
2.6 STUDY ASSUMPTIONS 43
2.7 RISK ASSESSMENT 44
3 EXECUTIVE SUMMARY 45
4 PREMIUM INSIGHTS 49
4.1 PEN NEEDLES MARKET OVERVIEW 49
4.2 ASIA PACIFIC: PEN NEEDLES MARKET, BY LENGTH AND COUNTRY (2024) 50
4.3 GEOGRAPHIC GROWTH OPPORTUNITIES 51
4.4 REGIONAL MIX 51
5 MARKET OVERVIEW 52
5.1 INTRODUCTION 52
5.2 MARKET DYNAMICS 52
5.2.1 DRIVERS 53
5.2.1.1 Rising incidence of chronic diseases 53
5.2.1.2 Favorable reimbursements in certain countries 54
5.2.1.3 Growing adoption of self-administration 54
5.2.1.4 Decreasing prices of insulin formulations 55
5.2.2 RESTRAINTS 56
5.2.2.1 Alternative methods of drug delivery 56
5.2.2.2 Poor reimbursement scenario in emerging markets 56
5.2.2.3 Needle anxiety 56
5.2.3 OPPORTUNITIES 57
5.2.3.1 Growing preference for biosimilar drugs 57
5.2.3.2 Emerging economies to offer high-growth potential 57
5.2.3.3 Rising healthcare expenditure on diabetes 57
5.2.3.4 Implementation of regulations for safety pen needles 58
5.2.4 CHALLENGES 58
5.2.4.1 Reuse of pen needles 58
5.2.4.2 Misuse of injection pens 59
5.3 INDUSTRY TRENDS 59
5.3.1 GROWING PREFERENCE FOR SAFETY-ENGINEERED PEN NEEDLES 59
5.3.2 RISING ADOPTION OF SHORTER AND ULTRA-THIN NEEDLES 60
5.4 REIMBURSEMENT SCENARIO 61
5.5 PRICING ANALYSIS 62
5.5.1 INDICATIVE SELLING PRICE OF PEN NEEDLES, BY KEY PLAYER, 2024 62
5.5.2 AVERAGE SELLING PRICE TREND OF STANDARD PEN NEEDLES,
BY REGION, 2022–2024 64
5.6 VALUE CHAIN ANALYSIS 64
5.7 ECOSYSTEM ANALYSIS 65
5.8 PORTER’S FIVE FORCES ANALYSIS 67
5.8.1 INTENSITY OF COMPETITIVE RIVALRY 68
5.8.2 BARGAINING POWER OF SUPPLIERS 68
5.8.3 BARGAINING POWER OF BUYERS 69
5.8.4 THREAT OF SUBSTITUTES 69
5.8.5 THREAT OF NEW ENTRANTS 69
5.9 SUPPLY CHAIN ANALYSIS 70
5.10 REGULATORY ANALYSIS 71
5.10.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 72
5.10.2 REGULATORY FRAMEWORK 75
5.10.2.1 North America 75
5.10.2.1.1 US 75
5.10.2.1.2 Canada 75
5.10.2.2 Europe 77
5.10.2.3 Asia Pacific 77
5.10.2.3.1 Japan 77
5.10.2.3.2 China 78
5.10.2.3.3 India 79
5.11 TRADE ANALYSIS 80
5.11.1 TRADE ANALYSIS OF NEEDLES, CATHETERS, AND CANNULAE USED IN MEDICAL, SURGICAL, DENTAL, OR VETERINARY SCIENCES
(HS CODE 901839) 80
5.11.2 EXPORT DATA (HS CODE 901839), 2019–2023 80
5.11.3 IMPORT DATA (HS CODE 901839), 2019–2023 81
5.12 PATENT ANALYSIS 81
5.12.1 PATENT PUBLICATION TRENDS FOR PEN NEEDLES 81
5.12.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 82
5.13 KEY STAKEHOLDERS & BUYING CRITERIA 85
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 85
5.13.2 BUYING CRITERIA 86
5.14 CASE STUDY ANALYSIS 87
5.14.1 CASE STUDY 1: IMPACT OF CCG-WIDE INSULIN PEN NEEDLE 87
5.14.2 CASE STUDY 2: PEN NEEDLE DESIGN INFLUENCES EASE INSERTION,
PAIN, AND SKIN TRAUMA IN SUBJECTS WITH TYPE 2 DIABETES 88
5.14.3 CASE STUDY 3: DROPSAFE SAFETY PEN NEEDLE HELPS TO PREVENT ACCIDENTAL NEEDLESTICKS AFTER INJECTIONS 89
5.15 TECHNOLOGY ANALYSIS 89
5.15.1 KEY TECHNOLOGIES 89
5.15.1.1 Fluid flow enhancement technology 89
5.15.1.2 Ultra-thin needle technology 90
5.15.2 COMPLEMENTARY TECHNOLOGIES 90
5.15.2.1 Microfabricated needles 90
5.15.2.2 AI in pen injectors 90
5.15.3 ADJACENT TECHNOLOGIES 91
5.15.3.1 Autoinjectors 91
5.16 KEY CONFERENCES & EVENTS, 2025–2026 92
5.17 ADJACENT MARKET ANALYSIS 93
5.17.1 AUTOINJECTORS MARKET 93
5.17.2 INSULIN DELIVERY DEVICES MARKET 95
5.17.3 INJECTION PENS MARKET 96
5.17.4 NEEDLES MARKET 97
5.18 IMPACT OF AI/GEN AI ON PEN NEEDLES MARKET 97
5.19 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESS 98
5.20 UNMET NEEDS ANALYSIS 99
5.21 INVESTMENT & FUNDING SCENARIO 100
?
6 PEN NEEDLES MARKET, BY TYPE 102
6.1 INTRODUCTION 103
6.2 STANDARD PEN NEEDLES 103
6.2.1 GREATER PREFERENCE AND AFFORDABILITY OF STANDARD PEN NEEDLES TO SUPPORT GROWTH 103
6.3 SAFETY PEN NEEDLES 106
6.3.1 GROWING CONCERNS OVER NEEDLESTICK INJURIES TO DRIVE ADOPTION OF SAFETY PEN NEEDLES 106
7 PEN NEEDLES MARKET, BY LENGTH 108
7.1 INTRODUCTION 109
7.2 8MM 110
7.2.1 WIDE ADOPTION IN NORTH AMERICA TO BOOST MARKET GROWTH 110
7.3 5MM 112
7.3.1 SHORTER LENGTH AND LOW PAIN TO FUEL UPTAKE 112
7.4 6MM 114
7.4.1 FAVORABLE REIMBURSEMENTS TO BOOST DEMAND 114
7.5 4MM 116
7.5.1 WIDE ADOPTION IN PEDIATRIC INSULIN DELIVERY TO DRIVE DEMAND 116
7.6 12MM 118
7.6.1 HIGH UTILIZATION OF SHORTER NEEDLES TO LIMIT ADOPTION 118
7.7 10MM 120
7.7.1 PAINFUL PROCEDURES TO RESTRAIN ADOPTION 120
8 PEN NEEDLES MARKET, BY APPLICATION 122
8.1 INTRODUCTION 123
8.2 INSULIN THERAPY 123
8.2.1 RISING INCIDENCE OF DIABETES TO PROPEL MARKET 123
8.3 GLUCAGON-LIKE PEPTIDE-1 THERAPY 125
8.3.1 GROWING FOCUS OF PHARMA COMPANIES ON GLP-1 DRUG DEVELOPMENT TO DRIVE MARKET 125
8.4 GROWTH HORMONE THERAPY 126
8.4.1 AVAILABILITY OF LONG-ACTING TREATMENTS TO AFFECT DEMAND FOR NEEDLES 126
8.5 OSTEOPOROSIS 128
8.5.1 RISING VITAMIN D DEFICIENCY CASES TO PROPEL MARKET 128
8.6 OTHER APPLICATIONS 129
9 PEN NEEDLES MARKET, BY MODE OF PURCHASE 131
9.1 INTRODUCTION 132
9.2 PRESCRIPTION-BASED PURCHASE 132
9.2.1 RETAIL PURCHASES TO SUPPORT MARKET GROWTH 132
?
9.3 OTC PURCHASES 133
9.3.1 DISCOUNTS OFFERED BY LOCAL PHARMACIES, SUPPLIERS, AND DISTRIBUTORS TO DRIVE MARKET 133
9.4 ONLINE PURCHASE 134
9.4.1 CONVENIENCE AND TIME-EFFICIENT BENEFITS TO PROPEL MARKET 134
9.5 OTHER MODES OF PURCHASE 135
10 PEN NEEDLES MARKET, BY CARE SETTING 138
10.1 INTRODUCTION 139
10.2 HOME CARE SETTINGS 139
10.2.1 GROWING PREFERENCE FOR SELF-ADMINISTRATION OF INSULIN TO PROPEL MARKET 139
10.3 HOSPITALS & CLINICS 140
10.3.1 INCREASING ADOPTION OF SAFETY PEN NEEDLES TO DRIVE MARKET 140
10.4 OTHER CARE SETTINGS 142
11 PEN NEEDLES MARKET, BY REGION 143
11.1 INTRODUCTION 144
11.2 NORTH AMERICA 144
11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 144
11.2.2 US 148
11.2.2.1 Increasing burden of diabetes to contribute to growth 148
11.2.3 CANADA 151
11.2.3.1 Growing initiatives for diabetic coverage to drive market 151
11.3 EUROPE 154
11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 154
11.3.2 GERMANY 157
11.3.2.1 Advanced healthcare system to intensify growth 157
11.3.3 UK 160
11.3.3.1 High incidence of cardiovascular disease to favor growth 160
11.3.4 FRANCE 163
11.3.4.1 Growing delivery of insulin devices to propel market 163
11.3.5 ITALY 166
11.3.5.1 Low product pricing to support growth 166
11.3.6 SPAIN 168
11.3.6.1 Supportive regulations mandating the use of safety pen needles to propel market 168
11.3.7 REST OF EUROPE 171
11.4 ASIA PACIFIC 173
11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 173
11.4.2 JAPAN 178
11.4.2.1 Growing inclination toward public health insurance to boost market 178
?
11.4.3 CHINA 180
11.4.3.1 Rising focus on modernizing healthcare to expedite growth 180
11.4.4 AUSTRALIA & NEW ZEALAND 183
11.4.4.1 Increasing rate of chronic diseases to amplify growth 183
11.4.5 INDIA 185
11.4.5.1 Growing per capita income to fuel market 185
11.4.6 SOUTH KOREA 187
11.4.6.1 Increasing geriatric population to facilitate growth 187
11.4.7 SOUTHEAST ASIA 190
11.4.7.1 Booming medical tourism industry to drive market 190
11.4.8 REST OF ASIA PACIFIC 193
11.5 LATIN AMERICA 195
11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 195
11.5.2 BRAZIL 197
11.5.2.1 Growing incidence of non-communicable diseases to drive market 197
11.5.3 MEXICO 200
11.5.3.1 Universal health coverage to stimulate growth 200
11.5.4 ARGENTINA 202
11.5.4.1 Increasing obesity rates to bolster growth 202
11.5.5 REST OF LATIN AMERICA 205
11.6 MIDDLE EAST & AFRICA 207
11.6.1 INCREASING PREVALENCE OF CHRONIC DISEASES TO AUGMENT GROWTH 207
11.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 207
11.7 GCC COUNTRIES 209
11.7.1 HIGHER DISPOSABLE INCOME TO ENCOURAGE GROWTH 209
11.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES 210
12 COMPETITIVE LANDSCAPE 213
12.1 INTRODUCTION 213
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 213
12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PEN NEEDLES MARKET 214
12.3 REVENUE ANALYSIS, 2019–2023 215
12.4 MARKET SHARE ANALYSIS, 2023 215
12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 217
12.5.1 STARS 217
12.5.2 EMERGING LEADERS 217
12.5.3 PERVASIVE PLAYERS 217
12.5.4 PARTICIPANTS 218
12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 219
12.5.5.1 Company footprint 219
12.5.5.2 Region footprint 220
12.5.5.3 Type footprint 221
12.5.5.4 Length footprint 222
12.5.5.5 Application footprint 223
12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 224
12.6.1 PROGRESSIVE COMPANIES 224
12.6.2 RESPONSIVE COMPANIES 224
12.6.3 DYNAMIC COMPANIES 224
12.6.4 STARTING BLOCKS 224
12.6.5 COMPETITIVE BENCHMARKING 226
12.6.5.1 Detailed list of key startups/SMEs 226
12.6.5.2 Competitive benchmarking of key startups/SMEs 227
12.7 COMPANY VALUATION & FINANCIAL METRICS 227
12.8 COMPETITIVE SCENARIO 229
12.8.1 PRODUCT LAUNCHES & APPROVALS 229
12.8.2 DEALS 229
12.8.3 EXPANSIONS 230
12.9 BRAND/PRODUCT COMPARISON 231
12.10 R&D EXPENDITURE OF KEY PLAYERS 232
13 COMPANY PROFILES 233
13.1 KEY PLAYERS 233
13.1.1 EMBECTA CORP. 233
13.1.1.1 Business overview 233
13.1.1.2 Products offered 234
13.1.1.3 Recent developments 235
13.1.1.3.1 Deals 235
13.1.1.3.2 Expansions 235
13.1.1.3.3 Other developments 236
13.1.1.4 MnM view 236
13.1.1.4.1 Right to win 236
13.1.1.4.2 Strategic choices 236
13.1.1.4.3 Weaknesses & competitive threats 236
13.1.2 NOVO NORDISK A/S 237
13.1.2.1 Business overview 237
13.1.2.2 Products offered 238
13.1.2.3 Recent developments 239
13.1.2.3.1 Expansions 239
13.1.2.4 MnM view 239
13.1.2.4.1 Right to win 239
13.1.2.4.2 Strategic choices 239
13.1.2.4.3 Weaknesses & competitive threats 239
?
13.1.3 B. BRAUN SE 240
13.1.3.1 Business overview 240
13.1.3.2 Products offered 241
13.1.3.3 MnM view 242
13.1.3.3.1 Right to win 242
13.1.3.3.2 Strategic choices 242
13.1.3.3.3 Weaknesses & competitive threats 242
13.1.4 YPSOMED 243
13.1.4.1 Business overview 243
13.1.4.2 Products offered 245
13.1.4.3 Recent developments 245
13.1.4.3.1 Deals 245
13.1.4.4 MnM view 246
13.1.4.4.1 Right to win 246
13.1.4.4.2 Strategic choices 246
13.1.4.4.3 Weaknesses & competitive threats 246
13.1.5 TERUMO CORPORATION 247
13.1.5.1 Business overview 247
13.1.5.2 Products offered 248
13.1.5.3 MnM view 249
13.1.5.3.1 Right to win 249
13.1.5.3.2 Strategic choices 249
13.1.5.3.3 Weaknesses & competitive threats 249
13.1.6 NIPRO 250
13.1.6.1 Business overview 250
13.1.6.2 Products offered 251
13.1.6.3 Recent developments 252
13.1.6.3.1 Expansions 252
13.1.7 OWEN MUMFORD 254
13.1.7.1 Business overview 254
13.1.7.2 Products offered 254
13.1.7.3 Recent developments 255
13.1.7.3.1 Deals 255
13.1.8 ARKRAY, INC. 256
13.1.8.1 Business overview 256
13.1.8.2 Products offered 256
13.1.8.3 Recent developments 257
13.1.8.3.1 Expansions 257
13.1.9 ULTIMED, INC. 258
13.1.9.1 Business overview 258
13.1.9.2 Products offered 258
13.1.9.3 Recent developments 259
13.1.9.3.1 Product launches 259
13.1.10 HINDUSTAN SYRINGES & MEDICAL DEVICES LTD. 260
13.1.10.1 Business overview 260
13.1.10.2 Products offered 260
13.1.11 MONTM?D 261
13.1.11.1 Business overview 261
13.1.11.2 Products offered 261
13.1.11.3 Recent developments 261
13.1.11.3.1 Product approvals 261
13.1.11.3.2 Deals 262
13.1.12 HTL-STREFA 263
13.1.12.1 Business overview 263
13.1.12.2 Products offered 263
13.1.13 ALLISON MEDICAL, INC. 265
13.1.13.1 Business overview 265
13.1.13.2 Products offered 265
13.1.14 GLUCORX LIMITED 266
13.1.14.1 Business overview 266
13.1.14.2 Products offered 266
13.1.15 BERPU MEDICAL TECHNOLOGY CO., LTD. 267
13.1.15.1 Business overview 267
13.1.15.2 Products offered 267
13.2 OTHER PLAYERS 268
13.2.1 VAN HEEK MEDICAL 268
13.2.2 SIMPLE DIAGNOSTICS 269
13.2.3 IYON HEALTH MEDICAL 270
13.2.4 LINKS MEDICAL PRODUCTS INC. 271
13.2.5 MHC MEDICAL PRODUCTS, LLC 271
13.2.6 ADVACARE PHARMA 272
13.2.7 ARTSANA S.P.A. 273
13.2.8 PROMISEMED MEDICAL DEVICES, INC. 274
13.2.9 TRIVIDIA HEALTH, INC. 275
13.2.10 VOGT MEDICAL VERTRIEB GMBH 276
14 APPENDIX 277
14.1 DISCUSSION GUIDE 277
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 282
14.3 CUSTOMIZATION OPTIONS 284
14.4 RELATED REPORTS 284
14.5 AUTHOR DETAILS 285



List of Figures

FIGURE 1 MARKETS & REGIONS COVERED 26
FIGURE 2 RESEARCH DESIGN 30
FIGURE 3 PRIMARY SOURCES 32
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE):
BY COMPANY TYPE, DESIGNATION, AND REGION 34
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE):
BY CARE SETTING AND REGION 35
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 35
FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 36
FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: EMBECTA CORP. (2023) 37
FIGURE 9 PEN NEEDLES MARKET: REVENUE ANALYSIS OF TOP FIVE COMPANIES (2023) 37
FIGURE 10 DEMAND-SIDE ANALYSIS 38
FIGURE 11 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2024–2030) 40
FIGURE 12 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 40
FIGURE 13 TOP-DOWN APPROACH 41
FIGURE 14 DATA TRIANGULATION METHODOLOGY 42
FIGURE 15 PEN NEEDLES MARKET, BY TYPE, 2024 VS. 2030 (USD MILLION) 45
FIGURE 16 PEN NEEDLES MARKET, BY LENGTH, 2024 VS. 2030 (USD MILLION) 46
FIGURE 17 PEN NEEDLES MARKET, BY APPLICATION, 2024 VS. 2030 (USD MILLION) 46
FIGURE 18 PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2024 VS. 2030 (USD MILLION) 47
FIGURE 19 PEN NEEDLES MARKET, BY CARE SETTING, 2024 VS. 2030 (USD MILLION) 47
FIGURE 20 GEOGRAPHIC GROWTH OPPORTUNITIES 48
FIGURE 21 RISING INCIDENCE OF DIABETES TO PROPEL MARKET 49
FIGURE 22 8MM SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN
ASIA PACIFIC IN 2024 50
FIGURE 23 EMERGING MARKETS TO GROW AT HIGHER CAGRS DURING FORECAST PERIOD 51
FIGURE 24 NORTH AMERICA DOMINATED MARKET IN 2024 51
FIGURE 25 PEN NEEDLES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 52
FIGURE 26 NUMBER OF PEOPLE WITH CHRONIC CONDITIONS IN US 1995–2030 (MILLION INDIVIDUALS) 53
FIGURE 27 TYPE 1 DIABETIC POPULATION, BY COUNTRY (2022) 54
FIGURE 28 AVERAGE SELLING PRICE TREND OF STANDARD PEN NEEDLES, BY REGION, 2022–2024 (USD) 64
FIGURE 29 PEN NEEDLES MARKET: VALUE CHAIN ANALYSIS 65
FIGURE 30 PEN NEEDLES MARKET: ECOSYSTEM ANALYSIS 66
FIGURE 31 PEN NEEDLES MARKET: PORTER’S FIVE FORCES ANALYSIS 68
FIGURE 32 PEN NEEDLES MARKET: SUPPLY CHAIN ANALYSIS 71
FIGURE 33 CANADA: CLASS II MEDICAL DEVICE APPROVAL PROCESS 76
FIGURE 34 EUROPE: CE APPROVAL PROCESS FOR CLASS IIA MEDICAL DEVICES 77
FIGURE 35 PATENT PUBLICATION TRENDS (JANUARY 2014–DECEMBER 2024) 82
FIGURE 36 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR
PEN NEEDLE PATENTS (JANUARY 2014–DECEMBER 2024) 83
FIGURE 37 TOP APPLICANT COUNTRIES FOR PEN NEEDLE PATENTS
(JANUARY 2013–DECEMBER 2024) 84
FIGURE 38 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR
PEN NEEDLES 85
FIGURE 39 KEY BUYING CRITERIA FOR PEN NEEDLES, BY TYPE 86
FIGURE 40 AUTOINJECTORS MARKET OVERVIEW 94
FIGURE 41 INSULIN DELIVERY DEVICES MARKET OVERVIEW 95
FIGURE 42 INJECTION PENS MARKET OVERVIEW 96
FIGURE 43 NEEDLES MARKET OVERVIEW 97
FIGURE 44 IMPACT OF AI/GEN AI ON PEN NEEDLES MARKET 98
FIGURE 45 PEN NEEDLES MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 99
FIGURE 46 FUNDING AND NUMBER OF DEALS IN PEN NEEDLES MARKET 2018–2022 (USD MILLION) 100
FIGURE 47 NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2018–2022 101
FIGURE 48 VALUE OF INVESTOR DEALS, BY KEY PLAYER, 2018–2022 (USD MILLION) 101
FIGURE 49 NORTH AMERICA: PEN NEEDLES MARKET SNAPSHOT 145
FIGURE 50 TOTAL FERTILITY RATE IN US POPULATION, 1990?2024 148
FIGURE 51 ASIA PACIFIC: PEN NEEDLES MARKET SNAPSHOT 175
FIGURE 52 PREVALENCE OF DIABETES IN SOUTHEAST ASIA, 2021 VS. 2030 190
FIGURE 53 HEALTHCARE EXPENDITURE IN SOUTHEAST ASIA, 2021 (% GDP) 191
FIGURE 54 ELDERLY POPULATION IN SOUTHEAST ASIA, 2022 191
FIGURE 55 HEALTH EXPENDITURE IN LATIN AMERICA FOR 2021 (% GDP) 205
FIGURE 56 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN PEN NEEDLES MARKET 214
FIGURE 57 REVENUE ANALYSIS FOR KEY PLAYERS IN PEN NEEDLES MARKET (2019–2023) 215
FIGURE 58 MARKET SHARE ANALYSIS OF KEY PLAYERS IN PEN NEEDLES MARKET (2023) 216
FIGURE 59 PEN NEEDLES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 218
FIGURE 60 PEN NEEDLES MARKET: COMPANY FOOTPRINT 219
FIGURE 61 PEN NEEDLES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 225
FIGURE 62 EV/EBITDA OF KEY VENDORS 227
FIGURE 63 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK
BETA OF KEY VENDORS 228
FIGURE 64 PEN NEEDLES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 231
FIGURE 65 PEN NEEDLES MARKET: R&D EXPENDITURE OF KEY PLAYERS (2022 VS. 2023) 232
FIGURE 66 EMBECTA CORP.: COMPANY SNAPSHOT 234
FIGURE 67 NOVO NORDISK A/S: COMPANY SNAPSHOT 238
FIGURE 68 B. BRAUN SE: COMPANY SNAPSHOT 241
FIGURE 69 YPSOMED: COMPANY SNAPSHOT 244
FIGURE 70 TERUMO CORPORATION: COMPANY SNAPSHOT 248
FIGURE 71 NIPRO: COMPANY SNAPSHOT 251

List of Tables

TABLE 1 STANDARD CURRENCY CONVERSION RATES 27
TABLE 2 PEN NEEDLES MARKET: STUDY ASSUMPTIONS 43
TABLE 3 PEN NEEDLES MARKET: RISK ASSESSMENT ANALYSIS 44
TABLE 4 REIMBURSEMENT OF PEN NEEDLES, BY COUNTRY 61
TABLE 5 INDICATIVE SELLING PRICE OF PEN NEEDLES, BY KEY PLAYER, 2024 62
TABLE 6 PEN NEEDLES MARKET: ROLE IN ECOSYSTEM 66
TABLE 7 PEN NEEDLES MARKET: PORTER’S FIVE FORCES ANALYSIS 67
TABLE 8 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 72
TABLE 9 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 72
TABLE 10 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 73
TABLE 11 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 74
TABLE 12 US FDA: MEDICAL DEVICE CLASSIFICATION 75
TABLE 13 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 75
TABLE 14 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 76
TABLE 15 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 78
TABLE 16 CHINA: REGULATORY BODIES APPOINTED FOR MEDICAL DEVICE APPROVAL 78
TABLE 17 CHINA: CLASSIFICATION OF MEDICAL DEVICES 79
TABLE 18 TRADE ANALYSIS OF NEEDLES, CATHETERS, AND CANNULAE USED IN MEDICAL, SURGICAL, DENTAL, OR VETERINARY SCIENCES, 2023 (USD MILLION) 80
TABLE 19 EXPORT DATA FOR NEEDLES, CATHETERS, AND CANNULAE USED IN MEDICAL, SURGICAL, DENTAL, OR VETERINARY SCIENCES (HS CODE 901839), BY COUNTRY, 2019–2023 (USD THOUSAND) 80
TABLE 20 IMPORT DATA FOR NEEDLES, CATHETERS, AND CANNULAE USED IN MEDICAL, SURGICAL, DENTAL, OR VETERINARY SCIENCES (HS CODE 901839), BY COUNTRY, 2019–2023 (USD THOUSAND) 81
TABLE 21 PEN INJECTORS MARKET: MAJOR PATENTS 84
TABLE 22 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR PEN NEEDLES 86
TABLE 23 KEY BUYING CRITERIA FOR PEN NEEDLES 86
TABLE 24 IMPACT OF CCG-WIDE INSULIN PEN NEEDLE 87
TABLE 25 PEN NEEDLE DESIGN INFLUENCES EASE OF INSERTION, PAIN, AND SKIN
TRAUMA IN SUBJECTS WITH TYPE 2 DIABETES 88
TABLE 26 DROPSAFE SAFETY PEN NEEDLE HELPS TO PREVENT ACCIDENTAL NEEDLESTICKS AFTER INJECTIONS 89
TABLE 27 PEN NEEDLES MARKET: DETAILED LIST OF CONFERENCES & EVENTS
(2025–2026) 92
TABLE 28 PEN NEEDLES MARKET, BY TYPE, 2022–2030 (USD MILLION) 103
TABLE 29 STANDARD PEN NEEDLES OFFERED BY KEY PLAYERS 104
TABLE 30 STANDARD PEN NEEDLES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 105
TABLE 31 STANDARD PEN NEEDLES MARKET, BY REGION, 2022–2030 (MILLION UNITS) 105
TABLE 32 SAFETY PEN NEEDLES OFFERED BY KEY PLAYERS 106
TABLE 33 SAFETY PEN NEEDLES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 107
TABLE 34 SAFETY PEN NEEDLES MARKET, BY REGION, 2022–2030 (MILLION UNITS) 107
TABLE 35 PEN NEEDLES MARKET, BY LENGTH, 2022–2030 (USD MILLION) 109
TABLE 36 8MM PEN NEEDLES OFFERED BY KEY PLAYERS 110
TABLE 37 8MM PEN NEEDLES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 111
TABLE 38 5MM PEN NEEDLES OFFERED BY KEY PLAYERS 112
TABLE 39 5MM PEN NEEDLES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 113
TABLE 40 6MM PEN NEEDLES OFFERED BY KEY PLAYERS 114
TABLE 41 6MM PEN NEEDLES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 115
TABLE 42 4MM PEN NEEDLES OFFERED BY KEY PLAYERS 116
TABLE 43 4MM PEN NEEDLES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 117
TABLE 44 12MM PEN NEEDLES OFFERED BY KEY PLAYERS 118
TABLE 45 12MM PEN NEEDLES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 119
TABLE 46 10MM PEN NEEDLES OFFERED BY KEY PLAYERS 120
TABLE 47 10MM PEN NEEDLES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 121
TABLE 48 PEN NEEDLES MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 123
TABLE 49 PEN NEEDLES MARKET FOR INSULIN THERAPY, BY COUNTRY 2022–2030 (USD MILLION) 124
TABLE 50 PEN NEEDLES MARKET FOR GLP-1 THERAPY, BY COUNTRY 2022–2030 (USD MILLION) 126
TABLE 51 PEN NEEDLES MARKET FOR GROWTH HORMONE THERAPY, BY COUNTRY 2022–2030 (USD MILLION) 127
TABLE 52 PEN NEEDLES MARKET FOR OSTEOPOROSIS, BY COUNTRY 2022–2030 (USD MILLION) 128
TABLE 53 PEN NEEDLES MARKET FOR OTHER APPLICATIONS, BY COUNTRY 2022–2030 (USD MILLION) 130
TABLE 54 PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2022–2030 (USD MILLION) 132
TABLE 55 PEN NEEDLES MARKET FOR PRESCRIPTION-BASED PURCHASES, BY COUNTRY, 2022–2030 (USD MILLION) 133
TABLE 56 PEN NEEDLES MARKET FOR OTC PURCHASES, BY COUNTRY 2022–2030 (USD MILLION) 134
TABLE 57 PEN NEEDLES MARKET FOR ONLINE PURCHASES, BY COUNTRY 2022–2030 (USD MILLION) 135
TABLE 58 PEN NEEDLES MARKET FOR OTHER MODES OF PURCHASE, BY COUNTRY 2022–2030 (USD MILLION) 137
TABLE 59 PEN NEEDLES MARKET, BY CARE SETTING, 2022–2030 (USD MILLION) 139
TABLE 60 PEN NEEDLES MARKET FOR HOME CARE SETTINGS, BY COUNTRY 2022–2030 (USD MILLION) 140
TABLE 61 PEN NEEDLES MARKET FOR HOSPITALS & CLINICS, BY COUNTRY 2022–2030 (USD MILLION) 141
TABLE 62 PEN NEEDLES MARKET FOR OTHER CARE SETTINGS, BY COUNTRY 2022–2030 (USD MILLION) 142
TABLE 63 PEN NEEDLES MARKET, BY REGION, 2022–2030 (USD MILLION) 144
TABLE 64 NORTH AMERICA: PEN NEEDLES MARKET, BY COUNTRY 2022–2030 (USD MILLION) 146
TABLE 65 NORTH AMERICA: PEN NEEDLES MARKET, BY TYPE, 2022–2030 (USD MILLION) 146
TABLE 66 NORTH AMERICA: PEN NEEDLES MARKET, BY LENGTH 2022–2030 (USD MILLION) 146
TABLE 67 NORTH AMERICA: PEN NEEDLES MARKET, BY APPLICATION 2022–2030 (USD MILLION) 147
TABLE 68 NORTH AMERICA: PEN NEEDLES MARKET, BY MODE OF PURCHASE 2022–2030 (USD MILLION) 147
TABLE 69 NORTH AMERICA: PEN NEEDLES MARKET, BY CARE SETTING 2022–2030 (USD MILLION) 147
TABLE 70 MACROECONOMIC INDICATORS FOR US 149
TABLE 71 US: PEN NEEDLES MARKET, BY TYPE, 2022–2030 (USD MILLION) 149
TABLE 72 US: PEN NEEDLES MARKET, BY LENGTH, 2022–2030 (USD MILLION) 150
TABLE 73 US: PEN NEEDLES MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 150
TABLE 74 US: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2022–2030 (USD MILLION) 150
TABLE 75 US: PEN NEEDLES MARKET, BY CARE SETTING, 2022–2030 (USD MILLION) 151
TABLE 76 MACROECONOMIC INDICATORS FOR CANADA 152
TABLE 77 CANADA: PEN NEEDLES MARKET, BY TYPE, 2022–2030 (USD MILLION) 152
TABLE 78 CANADA: PEN NEEDLES MARKET, BY LENGTH, 2022–2030 (USD MILLION) 153
TABLE 79 CANADA: PEN NEEDLES MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 153
TABLE 80 CANADA: PEN NEEDLES MARKET, BY MODE OF PURCHASE 2022–2030 (USD MILLION) 153
TABLE 81 CANADA: PEN NEEDLES MARKET, BY CARE SETTING, 2022–2030 (USD MILLION) 154
TABLE 82 EUROPE: PEN NEEDLES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 155
TABLE 83 EUROPE: PEN NEEDLES MARKET, BY TYPE, 2022–2030 (USD MILLION) 155
TABLE 84 EUROPE: PEN NEEDLES MARKET, BY LENGTH, 2022–2030 (USD MILLION) 156
TABLE 85 EUROPE: PEN NEEDLES MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 156
TABLE 86 EUROPE: PEN NEEDLES MARKET, BY MODE OF PURCHASE 2022–2030 (USD MILLION) 156
TABLE 87 EUROPE: PEN NEEDLES MARKET, BY CARE SETTING, 2022–2030 (USD MILLION) 157
TABLE 88 MACROECONOMIC INDICATORS FOR GERMANY 158
TABLE 89 GERMANY: PEN NEEDLES MARKET, BY TYPE, 2022–2030 (USD MILLION) 158
TABLE 90 GERMANY: PEN NEEDLES MARKET, BY LENGTH, 2022–2030 (USD MILLION) 159
TABLE 91 GERMANY: PEN NEEDLES MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 159
TABLE 92 GERMANY: PEN NEEDLES MARKET, BY MODE OF PURCHASE 2022–2030 (USD MILLION) 159
TABLE 93 GERMANY: PEN NEEDLES MARKET, BY CARE SETTING, 2022–2030 (USD MILLION) 160
TABLE 94 MACROECONOMIC INDICATORS FOR UK 161
TABLE 95 UK: PEN NEEDLES MARKET, BY TYPE, 2022–2030 (USD MILLION) 161
TABLE 96 UK: PEN NEEDLES MARKET, BY LENGTH, 2022–2030 (USD MILLION) 162
TABLE 97 UK: PEN NEEDLES MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 162
TABLE 98 UK: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2022–2030 (USD MILLION) 162
TABLE 99 UK: PEN NEEDLES MARKET, BY CARE SETTING, 2022–2030 (USD MILLION) 163
TABLE 100 MACROECONOMIC INDICATORS FOR FRANCE 163
TABLE 101 FRANCE: PEN NEEDLES MARKET, BY TYPE, 2022–2030 (USD MILLION) 164
TABLE 102 FRANCE: PEN NEEDLES MARKET, BY LENGTH, 2022–2030 (USD MILLION) 164
TABLE 103 FRANCE: PEN NEEDLES MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 165
TABLE 104 FRANCE: PEN NEEDLES MARKET, BY MODE OF PURCHASE 2022–2030 (USD MILLION) 165
TABLE 105 FRANCE: PEN NEEDLES MARKET, BY CARE SETTING, 2022–2030 (USD MILLION) 165
TABLE 106 MACROECONOMIC INDICATORS FOR ITALY 166
TABLE 107 ITALY: PEN NEEDLES MARKET, BY TYPE, 2022–2030 (USD MILLION) 167
TABLE 108 ITALY: PEN NEEDLES MARKET, BY LENGTH, 2022–2030 (USD MILLION) 167
TABLE 109 ITALY: PEN NEEDLES MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 167
TABLE 110 ITALY: PEN NEEDLES MARKET, BY MODE OF PURCHASE 2022–2030 (USD MILLION) 168
TABLE 111 ITALY: PEN NEEDLES MARKET, BY CARE SETTING, 2022–2030 (USD MILLION) 168
TABLE 112 MACROECONOMIC INDICATORS FOR SPAIN 169
TABLE 113 SPAIN: PEN NEEDLES MARKET, BY TYPE, 2022–2030 (USD MILLION) 169
TABLE 114 SPAIN: PEN NEEDLES MARKET, BY LENGTH, 2022–2030 (USD MILLION) 170
TABLE 115 SPAIN: PEN NEEDLES MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 170
TABLE 116 SPAIN: PEN NEEDLES MARKET, BY MODE OF PURCHASE 2022–2030 (USD MILLION) 170
TABLE 117 SPAIN: PEN NEEDLES MARKET, BY CARE SETTING, 2022–2030 (USD MILLION) 171
TABLE 118 REST OF EUROPE: PEN NEEDLES MARKET, BY TYPE, 2022–2030 (USD MILLION) 171
TABLE 119 REST OF EUROPE: PEN NEEDLES MARKET, BY LENGTH 2022–2030 (USD MILLION) 172
TABLE 120 REST OF EUROPE: PEN NEEDLES MARKET, BY APPLICATION 2022–2030 (USD MILLION) 172
TABLE 121 REST OF EUROPE: PEN NEEDLES MARKET, BY MODE OF PURCHASE 2022–2030 (USD MILLION) 172
TABLE 122 REST OF EUROPE: PEN NEEDLES MARKET, BY CARE SETTING 2022–2030 (USD MILLION) 173
TABLE 123 ASIA PACIFIC: PEN NEEDLES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 176
TABLE 124 ASIA PACIFIC: PEN NEEDLES MARKET, BY TYPE, 2022–2030 (USD MILLION) 176
TABLE 125 ASIA PACIFIC: PEN NEEDLES MARKET, BY LENGTH, 2022–2030 (USD MILLION) 176
TABLE 126 ASIA PACIFIC: PEN NEEDLES MARKET, BY APPLICATION 2022–2030 (USD MILLION) 177
TABLE 127 ASIA PACIFIC: PEN NEEDLES MARKET, BY MODE OF PURCHASE 2022–2030 (USD MILLION) 177
TABLE 128 ASIA PACIFIC: PEN NEEDLES MARKET, BY CARE SETTING 2022–2030 (USD MILLION) 177
TABLE 129 MACROECONOMIC INDICATORS FOR JAPAN 178
TABLE 130 JAPAN: PEN NEEDLES MARKET, BY TYPE, 2022–2030 (USD MILLION) 179
TABLE 131 JAPAN: PEN NEEDLES MARKET, BY LENGTH, 2022–2030 (USD MILLION) 179
TABLE 132 JAPAN: PEN NEEDLES MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 179
TABLE 133 JAPAN: PEN NEEDLES MARKET, BY MODE OF PURCHASE 2022–2030 (USD MILLION) 180
TABLE 134 JAPAN: PEN NEEDLES MARKET, BY CARE SETTING, 2022–2030 (USD MILLION) 180
TABLE 135 MACROECONOMIC INDICATORS FOR CHINA 181
TABLE 136 CHINA: PEN NEEDLES MARKET, BY TYPE, 2022–2030 (USD MILLION) 181
TABLE 137 CHINA: PEN NEEDLES MARKET, BY LENGTH, 2022–2030 (USD MILLION) 182
TABLE 138 CHINA: PEN NEEDLES MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 182
TABLE 139 CHINA: PEN NEEDLES MARKET, BY MODE OF PURCHASE 2022–2030 (USD MILLION) 182
TABLE 140 CHINA: PEN NEEDLES MARKET, BY CARE SETTING, 2022–2030 (USD MILLION) 183
TABLE 141 AUSTRALIA & NEW ZEALAND: PEN NEEDLES MARKET, BY TYPE 2022–2030 (USD MILLION) 183
TABLE 142 AUSTRALIA & NEW ZEALAND: PEN NEEDLES MARKET, BY LENGTH 2022–2030 (USD MILLION) 184
TABLE 143 AUSTRALIA & NEW ZEALAND: PEN NEEDLES MARKET, BY APPLICATION 2022–2030 (USD MILLION) 184
TABLE 144 AUSTRALIA & NEW ZEALAND: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2022–2030 (USD MILLION) 184
TABLE 145 AUSTRALIA & NEW ZEALAND: PEN NEEDLES MARKET, BY CARE SETTING 2022–2030 (USD MILLION) 185
TABLE 146 MACROECONOMIC INDICATORS FOR INDIA 185
TABLE 147 INDIA: PEN NEEDLES MARKET, BY TYPE, 2022–2030 (USD MILLION) 186
TABLE 148 INDIA: PEN NEEDLES MARKET, BY LENGTH, 2022–2030 (USD MILLION) 186
TABLE 149 INDIA: PEN NEEDLES MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 186
TABLE 150 INDIA: PEN NEEDLES MARKET, BY MODE OF PURCHASE 2022–2030 (USD MILLION) 187
TABLE 151 INDIA: PEN NEEDLES MARKET, BY CARE SETTING, 2022–2030 (USD MILLION) 187
TABLE 152 MACROECONOMIC INDICATORS FOR SOUTH KOREA 188
TABLE 153 SOUTH KOREA: PEN NEEDLES MARKET, BY TYPE, 2022–2030 (USD MILLION) 188
TABLE 154 SOUTH KOREA: PEN NEEDLES MARKET, BY LENGTH, 2022–2030 (USD MILLION) 189
TABLE 155 SOUTH KOREA: PEN NEEDLES MARKET, BY APPLICATION 2022–2030 (USD MILLION) 189
TABLE 156 SOUTH KOREA: PEN NEEDLES MARKET, BY MODE OF PURCHASE 2022–2030 (USD MILLION) 189
TABLE 157 SOUTH KOREA: PEN NEEDLES MARKET, BY CARE SETTING 2022–2030 (USD MILLION) 190
TABLE 158 SOUTHEAST ASIA: PEN NEEDLES MARKET, BY TYPE, 2022–2030 (USD MILLION) 191
TABLE 159 SOUTHEAST ASIA: PEN NEEDLES MARKET, BY LENGTH 2022–2030 (USD MILLION) 192
TABLE 160 SOUTHEAST ASIA: PEN NEEDLES MARKET, BY APPLICATION 2022–2030 (USD MILLION) 192
TABLE 161 SOUTHEAST ASIA: PEN NEEDLES MARKET, BY MODE OF PURCHASE 2022–2030 (USD MILLION) 192
TABLE 162 SOUTHEAST ASIA: PEN NEEDLES MARKET, BY CARE SETTING 2022–2030 (USD MILLION) 193
TABLE 163 REST OF ASIA PACIFIC: PEN NEEDLES MARKET, BY TYPE 2022–2030 (USD MILLION) 193
TABLE 164 REST OF ASIA PACIFIC: PEN NEEDLES MARKET, BY LENGTH 2022–2030 (USD MILLION) 193
TABLE 165 REST OF ASIA PACIFIC: PEN NEEDLES MARKET, BY APPLICATION 2022–2030 (USD MILLION) 194
TABLE 166 REST OF ASIA PACIFIC: PEN NEEDLES MARKET, BY MODE OF PURCHASE 2022–2030 (USD MILLION) 194
TABLE 167 REST OF ASIA PACIFIC: PEN NEEDLES MARKET, BY CARE SETTING 2022–2030 (USD MILLION) 194
TABLE 168 LATIN AMERICA: PEN NEEDLES MARKET, BY COUNTRY 2022–2030 (USD MILLION) 195
TABLE 169 LATIN AMERICA: PEN NEEDLES MARKET, BY TYPE, 2022–2030 (USD MILLION) 196
TABLE 170 LATIN AMERICA: PEN NEEDLES MARKET, BY LENGTH, 2022–2030 (USD MILLION) 196
TABLE 171 LATIN AMERICA: PEN NEEDLES MARKET, BY APPLICATION 2022–2030 (USD MILLION) 196
TABLE 172 LATIN AMERICA: PEN NEEDLES MARKET, BY MODE OF PURCHASE 2022–2030 (USD MILLION) 197
TABLE 173 LATIN AMERICA: PEN NEEDLES MARKET, BY CARE SETTING 2022–2030 (USD MILLION) 197
TABLE 174 MACROECONOMIC INDICATORS FOR BRAZIL 198
TABLE 175 BRAZIL: PEN NEEDLES MARKET, BY TYPE, 2022–2030 (USD MILLION) 198
TABLE 176 BRAZIL: PEN NEEDLES MARKET, BY LENGTH, 2022–2030 (USD MILLION) 199
TABLE 177 BRAZIL: PEN NEEDLES MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 199
TABLE 178 BRAZIL: PEN NEEDLES MARKET, BY MODE OF PURCHASE 2022–2030 (USD MILLION) 199
TABLE 179 BRAZIL: PEN NEEDLES MARKET, BY CARE SETTING, 2022–2030 (USD MILLION) 200
TABLE 180 MACROECONOMIC INDICATORS FOR MEXICO 200
TABLE 181 MEXICO: PEN NEEDLES MARKET, BY TYPE, 2022–2030 (USD MILLION) 201
TABLE 182 MEXICO: PEN NEEDLES MARKET, BY LENGTH, 2022–2030 (USD MILLION) 201
TABLE 183 MEXICO: PEN NEEDLES MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 201
TABLE 184 MEXICO: PEN NEEDLES MARKET, BY MODE OF PURCHASE 2022–2030 (USD MILLION) 202
TABLE 185 MEXICO: PEN NEEDLES MARKET, BY CARE SETTING, 2022–2030 (USD MILLION) 202
TABLE 186 MACROECONOMIC INDICATORS FOR ARGENTINA 203
TABLE 187 ARGENTINA: PEN NEEDLES MARKET, BY TYPE, 2022–2030 (USD MILLION) 203
TABLE 188 ARGENTINA: PEN NEEDLES MARKET, BY LENGTH, 2022–2030 (USD MILLION) 204
TABLE 189 ARGENTINA: PEN NEEDLES MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 204
TABLE 190 ARGENTINA: PEN NEEDLES MARKET, BY MODE OF PURCHASE 2022–2030 (USD MILLION) 204
TABLE 191 ARGENTINA: PEN NEEDLES MARKET, BY CARE SETTING 2022–2030 (USD MILLION) 205
TABLE 192 REST OF LATIN AMERICA: PEN NEEDLES MARKET, BY TYPE 2022–2030 (USD MILLION) 205
TABLE 193 REST OF LATIN AMERICA: PEN NEEDLES MARKET, BY LENGTH 2022–2030 (USD MILLION) 206
TABLE 194 REST OF LATIN AMERICA: PEN NEEDLES MARKET, BY APPLICATION 2022–2030 (USD MILLION) 206
TABLE 195 REST OF LATIN AMERICA: PEN NEEDLES MARKET, BY MODE OF PURCHASE 2022–2030 (USD MILLION) 206
TABLE 196 REST OF LATIN AMERICA: PEN NEEDLES MARKET, BY CARE SETTING 2022–2030 (USD MILLION) 207
TABLE 197 MIDDLE EAST & AFRICA: PEN NEEDLES MARKET, BY TYPE 2022–2030 (USD MILLION) 208
TABLE 198 MIDDLE EAST & AFRICA: PEN NEEDLES MARKET, BY LENGTH 2022–2030 (USD MILLION) 208
TABLE 199 MIDDLE EAST & AFRICA: PEN NEEDLES MARKET, BY APPLICATION 2022–2030 (USD MILLION) 208
TABLE 200 MIDDLE EAST & AFRICA: PEN NEEDLES MARKET, BY MODE OF PURCHASE 2022–2030 (USD MILLION) 209
TABLE 201 MIDDLE EAST & AFRICA: PEN NEEDLES MARKET, BY CARE SETTING 2022–2030 (USD MILLION) 209
TABLE 202 GCC COUNTRIES: PEN NEEDLES MARKET, BY TYPE, 2022–2030 (USD MILLION) 210
TABLE 203 GCC COUNTRIES: PEN NEEDLES MARKET, BY LENGTH, 2022–2030 (USD MILLION) 211
TABLE 204 GCC COUNTRIES: PEN NEEDLES MARKET, BY APPLICATION 2022–2030 (USD MILLION) 211
TABLE 205 GCC COUNTRIES: PEN NEEDLES MARKET, BY MODE OF PURCHASE 2022–2030 (USD MILLION) 211
TABLE 206 GCC COUNTRIES: PEN NEEDLES MARKET, BY CARE SETTING 2022–2030 (USD MILLION) 212
TABLE 207 PEN NEEDLES MARKET: DEGREE OF COMPETITION 216
TABLE 208 PEN NEEDLES MARKET: REGION FOOTPRINT 220
TABLE 209 PEN NEEDLES MARKET: TYPE FOOTPRINT 221
TABLE 210 PEN NEEDLES MARKET: LENGTH FOOTPRINT 222
TABLE 211 PEN NEEDLES MARKET: APPLICATION FOOTPRINT 223
TABLE 212 PEN NEEDLES MARKET: DETAILED LIST OF KEY STARTUPS/SMES 226
TABLE 213 PEN NEEDLES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 227
TABLE 214 PEN NEEDLES MARKET: PRODUCT LAUNCHES & APPROVALS JANUARY 2021- JANUARY 2025 229
TABLE 215 PEN NEEDLES MARKET: DEALS, JANUARY 2021– JANUARY 2025 229
TABLE 216 PEN NEEDLES MARKET: EXPANSIONS, JANUARY 2021– JANUARY 2025 230
TABLE 217 EMBECTA CORP.: COMPANY OVERVIEW 233
TABLE 218 EMBECTA CORP.: PRODUCTS OFFERED 234
TABLE 219 EMBECTA CORP.: DEALS, JANUARY 2021–JANUARY 2025 235
TABLE 220 EMBECTA CORP.: EXPANSIONS, JANUARY 2021–JANUARY 2025 235
TABLE 221 EMBECTA CORP.: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025 236
TABLE 222 NOVO NORDISK A/S: COMPANY OVERVIEW 237
TABLE 223 NOVO NORDISK A/S: PRODUCTS OFFERED 238
TABLE 224 NOVO NORDISK A/S: EXPANSIONS, JANUARY 2021–JANUARY 2025 239
TABLE 225 B. BRAUN SE: COMPANY OVERVIEW 240
TABLE 226 B. BRAUN SE: PRODUCTS OFFERED 241
TABLE 227 YPSOMED: COMPANY OVERVIEW 243
TABLE 228 YPSOMED: PRODUCTS OFFERED 245
TABLE 229 YPSOMED: DEALS, JANUARY 2021–JANUARY 2025 245
TABLE 230 TERUMO CORPORATION: COMPANY OVERVIEW 247
TABLE 231 TERUMO CORPORATION: PRODUCTS OFFERED 248
TABLE 232 NIPRO: COMPANY OVERVIEW 250
TABLE 233 NIPRO: PRODUCTS OFFERED 251
TABLE 234 NIPRO: EXPANSIONS, JANUARY 2021–JANUARY 2025 252
TABLE 235 OWEN MUMFORD: COMPANY OVERVIEW 254
TABLE 236 OWEN MUMFORD: PRODUCTS OFFERED 254
TABLE 237 OWEN MUMFORD: DEALS, JANUARY 2021–JANUARY 2025 255
TABLE 238 ARKRAY, INC.: COMPANY OVERVIEW 256
TABLE 239 ARKRAY, INC.: PRODUCTS OFFERED 256
TABLE 240 ARKRAY, INC.: EXPANSIONS, JANUARY 2021–JANUARY 2025 257
TABLE 241 ULTIMED, INC.: COMPANY OVERVIEW 258
TABLE 242 ULTIMED, INC.: PRODUCTS OFFERED 258
TABLE 243 ULTIMED, INC.: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2025 259
TABLE 244 HINDUSTAN SYRINGES & MEDICAL DEVICES LTD.: COMPANY OVERVIEW 260
TABLE 245 HINDUSTAN SYRINGES & MEDICAL DEVICES LTD.: PRODUCTS OFFERED 260
TABLE 246 MONTM?D: COMPANY OVERVIEW 261
TABLE 247 MONTM?D: PRODUCTS OFFERED 261
TABLE 248 MONTM?D: PRODUCT APPROVALS, JANUARY 2021–JANUARY 2025 261
TABLE 249 MONTM?D: DEALS, JANUARY 2021–JANUARY 2025 262
TABLE 250 HTL-STREFA: COMPANY OVERVIEW 263
TABLE 251 HTL-STREFA: PRODUCTS OFFERED 263
TABLE 252 ALLISON MEDICAL, INC.: COMPANY OVERVIEW 265
TABLE 253 ALLISON MEDICAL, INC.: PRODUCTS OFFERED 265
TABLE 254 GLUCORX LIMITED: COMPANY OVERVIEW 266
TABLE 255 GLUCORX LIMITED: PRODUCTS OFFERED 266
TABLE 256 BERPU MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW 267
TABLE 257 BERPU MEDICAL TECHNOLOGY CO., LTD.: PRODUCTS OFFERED 267
TABLE 258 VAN HEEK MEDICAL: COMPANY OVERVIEW 268
TABLE 259 SIMPLE DIAGNOSTICS: COMPANY OVERVIEW 269
TABLE 260 IYON HEALTH MEDICAL: COMPANY OVERVIEW 270
TABLE 261 LINKS MEDICAL PRODUCTS INC.: COMPANY OVERVIEW 271
TABLE 262 MHC MEDICAL PRODUCTS, LLC: COMPANY OVERVIEW 271
TABLE 263 ADVACARE PHARMA: COMPANY OVERVIEW 272
TABLE 264 ARTSANA S.P.A.: COMPANY OVERVIEW 273
TABLE 265 PROMISEMED MEDICAL DEVICES, INC.: COMPANY OVERVIEW 274
TABLE 266 TRIVIDIA HEALTH, INC.: COMPANY OVERVIEW 275
TABLE 267 VOGT MEDICAL VERTRIEB GMBH: COMPANY OVERVIEW 276